vs
Side-by-side financial comparison of GE HealthCare (GEHC) and Vistra Corp. (VST). Click either name above to swap in a different company.
GE HealthCare is the larger business by last-quarter revenue ($5.7B vs $4.8B, roughly 1.2× Vistra Corp.). GE HealthCare runs the higher net margin — 10.3% vs 4.8%, a 5.5% gap on every dollar of revenue. On growth, Vistra Corp. posted the faster year-over-year revenue change (31.2% vs 7.1%). Over the past eight quarters, Vistra Corp.'s revenue compounded faster (23.3% CAGR vs 10.7%).
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
Vistra may refer to either of two companies:Vistra, a corporate services company based in Hong Kong Vistra Corp, an energy company based in Texas
GEHC vs VST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.7B | $4.8B |
| Net Profit | $588.0M | $233.0M |
| Gross Margin | 39.7% | — |
| Operating Margin | 14.5% | 9.9% |
| Net Margin | 10.3% | 4.8% |
| Revenue YoY | 7.1% | 31.2% |
| Net Profit YoY | -18.4% | -47.2% |
| EPS (diluted) | $1.28 | $0.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.7B | $4.8B | ||
| Q3 25 | $5.1B | $4.8B | ||
| Q2 25 | $5.0B | $3.8B | ||
| Q1 25 | $4.8B | $4.3B | ||
| Q4 24 | $5.3B | $3.7B | ||
| Q3 24 | $4.9B | $4.3B | ||
| Q2 24 | $4.8B | $3.6B | ||
| Q1 24 | $4.7B | $3.2B |
| Q4 25 | $588.0M | $233.0M | ||
| Q3 25 | $446.0M | $652.0M | ||
| Q2 25 | $486.0M | $327.0M | ||
| Q1 25 | $564.0M | $-268.0M | ||
| Q4 24 | $721.0M | $441.0M | ||
| Q3 24 | $470.0M | $1.9B | ||
| Q2 24 | $428.0M | $365.0M | ||
| Q1 24 | $374.0M | $-35.0M |
| Q4 25 | 39.7% | — | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 39.6% | — | ||
| Q1 25 | 42.1% | — | ||
| Q4 24 | 42.8% | — | ||
| Q3 24 | 41.7% | — | ||
| Q2 24 | 41.4% | — | ||
| Q1 24 | 40.9% | — |
| Q4 25 | 14.5% | 9.9% | ||
| Q3 25 | 12.7% | 21.7% | ||
| Q2 25 | 13.1% | 13.7% | ||
| Q1 25 | 13.2% | -2.8% | ||
| Q4 24 | 15.1% | 16.4% | ||
| Q3 24 | 13.9% | 59.6% | ||
| Q2 24 | 12.6% | 22.5% | ||
| Q1 24 | 11.6% | 2.7% |
| Q4 25 | 10.3% | 4.8% | ||
| Q3 25 | 8.7% | 13.6% | ||
| Q2 25 | 9.7% | 8.7% | ||
| Q1 25 | 11.8% | -6.3% | ||
| Q4 24 | 13.6% | 12.0% | ||
| Q3 24 | 9.7% | 43.5% | ||
| Q2 24 | 8.8% | 10.1% | ||
| Q1 24 | 8.0% | -1.1% |
| Q4 25 | $1.28 | $0.55 | ||
| Q3 25 | $0.98 | $1.75 | ||
| Q2 25 | $1.06 | $0.81 | ||
| Q1 25 | $1.23 | $-0.93 | ||
| Q4 24 | $1.58 | $1.09 | ||
| Q3 24 | $1.02 | $5.25 | ||
| Q2 24 | $0.93 | $0.90 | ||
| Q1 24 | $0.81 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.5B | $785.0M |
| Total DebtLower is stronger | $10.0B | $15.8B |
| Stockholders' EquityBook value | $10.4B | $5.1B |
| Total Assets | $36.9B | $41.5B |
| Debt / EquityLower = less leverage | 0.96× | 3.11× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.5B | $785.0M | ||
| Q3 25 | $4.0B | $602.0M | ||
| Q2 25 | $3.7B | $458.0M | ||
| Q1 25 | $2.5B | $561.0M | ||
| Q4 24 | $2.9B | $1.2B | ||
| Q3 24 | $3.5B | $905.0M | ||
| Q2 24 | $2.0B | $1.6B | ||
| Q1 24 | $2.6B | $1.1B |
| Q4 25 | $10.0B | $15.8B | ||
| Q3 25 | $10.3B | $15.8B | ||
| Q2 25 | $10.3B | $15.5B | ||
| Q1 25 | $8.8B | $15.4B | ||
| Q4 24 | $9.0B | $15.4B | ||
| Q3 24 | $10.3B | $13.9B | ||
| Q2 24 | $9.2B | $13.9B | ||
| Q1 24 | $9.3B | $14.7B |
| Q4 25 | $10.4B | $5.1B | ||
| Q3 25 | $10.0B | $5.2B | ||
| Q2 25 | $9.7B | $4.8B | ||
| Q1 25 | $9.2B | $4.8B | ||
| Q4 24 | $8.4B | $5.6B | ||
| Q3 24 | $8.3B | $5.4B | ||
| Q2 24 | $7.8B | $5.6B | ||
| Q1 24 | $7.4B | $5.7B |
| Q4 25 | $36.9B | $41.5B | ||
| Q3 25 | $36.1B | $38.0B | ||
| Q2 25 | $35.5B | $38.1B | ||
| Q1 25 | $33.6B | $38.2B | ||
| Q4 24 | $33.1B | $37.8B | ||
| Q3 24 | $33.9B | $37.9B | ||
| Q2 24 | $31.9B | $39.1B | ||
| Q1 24 | $32.2B | $38.2B |
| Q4 25 | 0.96× | 3.11× | ||
| Q3 25 | 1.03× | 3.02× | ||
| Q2 25 | 1.06× | 3.22× | ||
| Q1 25 | 0.95× | 3.20× | ||
| Q4 24 | 1.06× | 2.77× | ||
| Q3 24 | 1.24× | 2.56× | ||
| Q2 24 | 1.18× | 2.49× | ||
| Q1 24 | 1.25× | 2.60× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $1.4B |
| Free Cash FlowOCF − Capex | — | $596.0M |
| FCF MarginFCF / Revenue | — | 12.4% |
| Capex IntensityCapex / Revenue | 2.4% | 17.4% |
| Cash ConversionOCF / Net Profit | — | 6.15× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | $94.0M | $572.0M | ||
| Q1 25 | $250.0M | $599.0M | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | $-119.0M | $1.2B | ||
| Q1 24 | $419.0M | $312.0M |
| Q4 25 | — | $596.0M | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | $8.0M | $-118.0M | ||
| Q1 25 | $98.0M | $-169.0M | ||
| Q4 24 | — | $923.0M | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | $-183.0M | $698.0M | ||
| Q1 24 | $274.0M | $-153.0M |
| Q4 25 | — | 12.4% | ||
| Q3 25 | — | 21.1% | ||
| Q2 25 | 0.2% | -3.1% | ||
| Q1 25 | 2.1% | -4.0% | ||
| Q4 24 | — | 25.2% | ||
| Q3 24 | — | 23.4% | ||
| Q2 24 | -3.8% | 19.4% | ||
| Q1 24 | 5.9% | -4.8% |
| Q4 25 | 2.4% | 17.4% | ||
| Q3 25 | 2.1% | 9.6% | ||
| Q2 25 | 1.7% | 18.4% | ||
| Q1 25 | 3.2% | 18.1% | ||
| Q4 24 | 1.9% | 11.7% | ||
| Q3 24 | 1.9% | 15.8% | ||
| Q2 24 | 1.3% | 13.8% | ||
| Q1 24 | 3.1% | 14.7% |
| Q4 25 | — | 6.15× | ||
| Q3 25 | — | 2.25× | ||
| Q2 25 | 0.19× | 1.75× | ||
| Q1 25 | 0.44× | — | ||
| Q4 24 | — | 3.07× | ||
| Q3 24 | — | 0.90× | ||
| Q2 24 | -0.28× | 3.28× | ||
| Q1 24 | 1.12× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
VST
| Retail Energy Charge In ERCOT | $2.1B | 43% |
| Retail Energy Charge In Northeast Midwest | $1.2B | 24% |
| East Segment | $1.1B | 24% |
| Hedging Revenue Realized | $170.0M | 4% |
| Revenue From Other Wholesale Contracts | $116.0M | 2% |
| Transferable Production Tax Credit Revenues | $78.0M | 2% |
| West Segment | $77.0M | 2% |
| Intersegment Sales | $25.0M | 1% |
